Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2019 | Inivata | $53.0M Series B | — | Cambridge Innovation Capital, Johnson & Johnson Innovation, RT Ventures |
| Jan 28, 2018 | Bodle Technologies | $8.5M Series A | Parkwalk Advisors | Oxford Science Enterprises, Oxford Technology and Innovations |
| Nov 24, 2016 | Kymab | $100.9M Series C | Simone Song | Bill & Melinda Gates Foundation, CF Woodford Equity Income Fund, Malin Corporation, Shenzhen Hepalink Pharmaceutical |
| Feb 2, 2016 | MISSION Therapeutics | $86.4M Other Equity | Imperial Innovations, Woodford Patient Capital Trust | Pfizer, Roche, Sofinnova Partners, SR One |
| Jan 1, 2016 | Inivata | $45.0M Series A | — | Cambridge Innovation Capital, Imperial Innovations, Johnson & Johnson Innovation |
| Jul 29, 2015 | Seedrs | $15.6M Series A | Tim Levene, Woodford Patient Capital Trust | — |
| May 6, 2015 | Kymab | $50.0M Series B Extension | Adrian Howd, Woodford Patient Capital Trust | — |